Drug companies are very attuned to competitive intelligence. There’s a lot of information sloshing around out there, and you’d be wise to pay attention to it. Publications in journals are probably the least of it – by the time something written up for publication from inside a pharma company, it’s either about to be on the drugstore shelves or it never will be at all. Patents are far more essential, and if you’re going to watch anything, you should watch the patent applications in your field.
See on pipeline.corante.com